| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 11/04/2010 | US20100278871 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| 11/04/2010 | US20100275913 Composition for inhalation |
| 11/03/2010 | EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 11/03/2010 | EP2246360A1 Compositions for the treatment of gastrointestinal disorders |
| 11/03/2010 | EP2246053A1 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 11/03/2010 | EP2246049A2 Pharmaceutical composition and dosage forms for administration of hydrophobic drugs |
| 11/03/2010 | CN1738634B Extract of stephaniae sinica diels and methods of using the same |
| 11/02/2010 | US7825279 Fused ring dicationic anti-protozoan agents and their prodrugs |
| 11/02/2010 | US7825109 Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 11/02/2010 | US7825084 human dietary supplement, comprising beta-alanine in unit dosage; regulating hydronium ion concentration; increasing beta-alanylhistidine dipeptide; insulin |
| 11/02/2010 | US7824712 Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof |
| 11/02/2010 | CA2389681C Npy y5 antagonist |
| 11/02/2010 | CA2281049C Water-soluble pharmaceutical composition in an ionic complex and the use thereof |
| 10/28/2010 | US20100273860 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION |
| 10/28/2010 | US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/28/2010 | US20100273732 Combination methods of treating cancer |
| 10/28/2010 | US20100273717 Use of an Extract from the Vigna Aconitifolia Plant in a Cosmetic and/or Dermopharmaceutical Composition |
| 10/27/2010 | EP2243484A2 Controlled release oxycodone compositions |
| 10/27/2010 | EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 10/27/2010 | CN101869535A Functional fragrance precursor |
| 10/26/2010 | US7820839 Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 10/26/2010 | US7820696 Compounds and methods for controlling fungi, bacteria and insects |
| 10/26/2010 | US7820671 Peptidomimetic protease inhibitors |
| 10/26/2010 | US7820638 Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density |
| 10/26/2010 | CA2533583C N-desmethyl-n-substituted-11-deoxyerythromycin compounds |
| 10/21/2010 | US20100267841 Composition for Topical Use Containing an Extract of Stryphnodendron; Its Preparation As Well As Its Application |
| 10/21/2010 | US20100267813 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 10/21/2010 | US20100267716 Methods of treating inflammations and infections with pyridinium salts |
| 10/21/2010 | US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof |
| 10/21/2010 | US20100267644 Cystatin C as an Antagonist of TGF-BETA and Methods Related Thereto |
| 10/21/2010 | US20100267638 Exosite-directed thrombin inhibitors |
| 10/21/2010 | US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins |
| 10/21/2010 | US20100267035 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS |
| 10/21/2010 | US20100266715 Composition for treating aids and associated conditions |
| 10/21/2010 | US20100266581 Compositions and methods for modulating s-nitrosogluthione reductase |
| 10/21/2010 | US20100266549 Novel probiotics for pet food applications |
| 10/21/2010 | US20100266534 Human Lymphocyte Vaccine Adjuvant |
| 10/20/2010 | EP2241572A2 Modulation of survivin expression |
| 10/20/2010 | EP2241331A2 Novel anti-DC-SIGN antibodies |
| 10/20/2010 | EP2241330A1 Contraceptive methods and compositions related to proteasomal interference |
| 10/20/2010 | EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness |
| 10/20/2010 | CN101863878A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 10/20/2010 | CN101862295A Aggregate having enhanced deformability and including at least three amphipatic substances |
| 10/20/2010 | CN101137326B Adrenergic imaging agent and its uses and related kit |
| 10/19/2010 | US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT |
| 10/19/2010 | US7816409 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol |
| 10/19/2010 | US7816403 Administering a thiuram disulfide and a heavy metal ion; activated transcription factor/adenosine cyclic phosphate response element binding protein (atf/creb) |
| 10/19/2010 | US7816372 (R)-6-(2-(2,2,2-Trifluoroethyl)-1-pyrrolidinyl)-4-trifluoromethyl-2(1H)-quinolinone; partial agonist, agonist or antagonist of androgen receptor; cachexia and wasting diseases; male-pattern baldness; benign prostatic hyperplasia; hirsutism; acne |
| 10/19/2010 | US7816353 P70S6 kinase modulators and method of use |
| 10/19/2010 | US7816331 Substituted indazole-O-glucosides |
| 10/19/2010 | US7816074 α4 β2 δGABA-A receptors as a strategy for PMS and alcoholism |
| 10/19/2010 | US7815943 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction |
| 10/19/2010 | US7815906 Compositions and methods for restoring sensitivity to treatment with HER2 antagonists |
| 10/19/2010 | CA2366896C Method for the purification, recovery, and sporulation of cysts and oocysts |
| 10/14/2010 | US20100260822 Surface protection of exposed biological tissues |
| 10/13/2010 | EP2239340A2 Identification of surface-oriented antigens for tumour diagnosis and treatment |
| 10/13/2010 | EP2239329A1 Therapeutic compositions |
| 10/13/2010 | CN1819821B Modified-release tablet of bupropion hydrochloride |
| 10/13/2010 | CN101856348A Combination methods of treating cancer |
| 10/12/2010 | US7811989 Peptide YY analogs |
| 10/12/2010 | US7811982 Compounds and methods for treating cancer |
| 10/12/2010 | US7811610 Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| 10/12/2010 | CA2526536C Sunscreen composition |
| 10/12/2010 | CA2419205C Anti-tnf antibodies, compositions, methods and uses |
| 10/12/2010 | CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 10/12/2010 | CA2336542C Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 10/07/2010 | US20100256171 Selective serine/threonine kinase inhibitors |
| 10/07/2010 | US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/07/2010 | US20100255106 Benzothiophenes, formulations containing same, and methods |
| 10/06/2010 | EP2236154A1 Immunoglobulin formulation and method of preparation thereof |
| 10/06/2010 | EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds |
| 10/06/2010 | EP1296951B1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3'] bipyridinyl in pure crystalline form and process for synthesis |
| 10/06/2010 | CN1690047B 9-substituted minocycline compounds |
| 10/06/2010 | CN101850108A Methods and pharmaceutical compositions for healing wounds |
| 10/06/2010 | CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 10/06/2010 | CN101849906A Methods for the treatment of endometriosis |
| 10/05/2010 | US7807658 Administering an optionally substituted 3-aminopropylphosphinic acid (3-amino-2-fluoropropyl)phosphinic acid, 3-amino-2-oxopropyl)phosphinic acid); irritable bowel syndrome |
| 10/05/2010 | US7807458 Nutrient broth comprising multipotent cells for use in propagation of mesodermal, neuroectodermal, and endodermal cells; tissue engineering |
| 10/05/2010 | US7807423 Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives |
| 10/05/2010 | US7807389 Diagnosing psoriatic and rheumatoid arthritis via presence of enhanced concentrations of osteoclast or osteoclast precursor cells |
| 10/05/2010 | US7807194 Plasticizer, film former, bulking agent, and pH controlling agent; |
| 10/05/2010 | US7807193 Method of treating insulin resistance, adult onset diabetes and metabolic syndrome X |
| 10/05/2010 | US7807167 using an agent that specifically binds to an alpha-4 integrin or a dimer comprising an alpha-4 integrin; treatment of multiple sclerosis or inflammatory disease of the gastrointestinal tract |
| 10/05/2010 | US7807106 Apparatus and method to measure platelet contractility |
| 09/30/2010 | US20100249849 Method for interconnecting longitudinal members extending along a spinal column |
| 09/30/2010 | US20100249215 Oligomeric Compounds And Compositions For Use In Modulation Of Pri-miRNAs |
| 09/30/2010 | US20100247689 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 09/30/2010 | US20100247561 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | CN1835910B 2-aminobenzoyl derivatives |
| 09/29/2010 | CN1753673B Prodrugs of GABA analogs, compositions and uses thereof |
| 09/29/2010 | CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843590A Extended release venlafaxine formulation |
| 09/28/2010 | US7803924 Polynucleotide encoding a protein that is highly immunogenic especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803557 Screening a candidate compound for antiinflammatory activity by administering the candidate in vivo to cells of an animal that express a Reso E receptor; reduced expression of interleukin-12 and reduced migration of dendritic cells into T-cell areas of the spleen indicates a good candidate |
| 09/28/2010 | CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity |
| 09/23/2010 | US20100241056 Face mask |